高迁移率族蛋白B1表达水平与患者脓毒症严重程度及预后关系的临床研究

Relationship between expression level of high mobility group protein B1 in hepatic tissue with the severity and prognosis of sepsis in patients

  • 摘要: 目的 分析临床高迁移率族蛋白B1(HMGB1)表达水平与脓毒症严重程度及其预后的关系,进行临床研究。方法 分析2014年4月-2015年6月医院救治脓毒症患者,将其分成脓毒症组27例和严重脓毒症组28例,对照组为31例,收集发生疾病24 h内临床血清HMGB1水平,以及预后21 d内临床血清HMGB1水平,应用酶联免疫吸附测定方式检查患者血清中HMGB1表达在发生疾病24 h以及预后21 d内。结果 通过临床试验检查患者发病24 h内血清HMGB1水平,结果对照组HMGB1(43.7±17.5) μg /L,脓毒症组HMGB1(82.9±24.8)μg/L,严重脓毒症组HMGB1(145.9±31.4) μg /L,3组比较差异有统计学意义(P<0.05),预后非存活组患者血浆HMGB1含量显著高于存活组。结论 脓毒症患者在发生疾病24 h内HMGB1表达水平显著提高,患者预后其表达很大程度的反应了脓毒症患病的严重性,及与患者预后高度相关。

     

    Abstract: OBJECTIVE To investigate the relationship between the expression levels of high mobility group protein B1 (HMGB1) in hepatic tissue with severity and prognosis of sepsis in patients. METHODS The sepsis patients from Apr. 2014 to Jun. 2015 in our hospital for treatment were analyzed, and divided into sepsis group(27 cases) and severe sepsis group(28 cases), and the control group had 31 cases. Clinical serum HMGB1 levels within 24 hours and within 21 days of prognosis were collected, and their expressions were determined by enzyme-linked immunosorbent assay. RESULTS Through the clinical examination, serum HMGB1 levels within 24 hours of onset of control group, sepsis group and severe sepsis group were (43.7±17.5) μg /L,(82.9±24.8)μg/L, (145.9±31.4) μg /L, respectively, which had significant differences (P<0.05). The plasma HMGB1 level of non-survival group of prognosis was significantly higher than that of the survival group. CONCLUSION HMGB1 expression in patients with sepsis was significantly increased within 24 hours of onset, and its expression of prognosis indicated the severity of sepsis, and was highly correlated with patient's prognosis.

     

/

返回文章
返回